Saturday, February 25, 2023 - Saturday, February 25, 2023
About this Event
6250 Hollywood Blvd. Hollywood, CA 90028
This one-day educational conference focuses on what is new and notable in interventional radiology. The conference will be separated into topic lecture sessions (including overviews of literature in a rapid-fire format), panel discussions, and a worst case/worst case session, where use of new and novel techniques will be featured in addition to morbidity/mortality. There will be a total of 6 hours of topic lectures and one hour of worst case/worst case for a total of 7.25 hours of educational content.
This conference will be targeted to interventional radiology residents and early career attending physicians in interventional radiology (in their first 10 years in practice), though all healthcare professionals are welcome.
Cancellations must be received by February 10, 2023 by email to firstname.lastname@example.org, and will be subject to a $25 processing fee. No refunds will be given after that date. If for any reason, the course must be canceled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided.
For any questions, please email email@example.com or call (310) 794-2620.
At the conclusion of this course, participants will be able to:
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 27.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The California State Board of Registered Nursing accepts courses approved for the AMA PRA Category 1 CreditsTM. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.
The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manage all identified potential conflicts of interest prior to the program. We, at UCLA, fully endorse the letter and spirit of these concepts.